Literature DB >> 15744455

Association analysis of signal transducer and activator of transcription 4 (STAT4) polymorphisms with asthma.

Byung Lae Park1, Hyun Sub Cheong1, Lyoung Hyo Kim1, Yoo Hyun Choi1, Sohg Namgoong1, Hae-Sim Park2, Soo-Jong Hong2, Byoung Whui Choi2, June Hyuk Lee2, Choon-Sik Park3,4, Hyoung Doo Shin1.   

Abstract

The signal transducer and activator of transcription 4 (STAT4) on chromosome 2q32.2-q32.3 is known to be essential for mediating responses to interleukin 12 in lymphocytes and regulating the differentiation of T helper cells. In an effort to discover additional polymorphism(s) in genes in which variant(s) have been implicated in asthma, we investigated the genetic polymorphisms in STAT4 to evaluate it as a potential candidate gene for a host genetic study of asthma. By direct DNA sequencing in 24 individuals, we identified 12 sequence variants within introns and their flanking regions, including the 1.5 kb promoter region of STAT4. Among them, seven common polymorphic sites were selected for genotyping in our asthma cohort (502 asthmatic patients, 164 normal controls). Using logistic regression analysis for association with the risk of asthma, while controlling for age, gender, and smoking status as covariates, no significant associations with the risk of asthma were detected. However, one single nucleotide polymorphism (SNP) in intron 11 (+90089T--> C) and two haplotypes showed positive association (P= 0.03, 0.03 and 0.03, respectively) with production of specific IgE to Dermatophagoides farinae (D.f.) or Dermatophagoides pteronyssinus (D.p.) among asthmatic patients. The minor allele frequencies of +90089T--> C and BLOCK2-ht1 were higher (0.54 and 0.47, respectively) among individuals who produced specific IgE to D.f. or D.p. than frequencies (0.47 and 0.39, respectively) among individuals who did not produce specific IgE (OR=1.38 and 1.40, respectively). Our findings suggest that polymorphisms in STAT4 might be one of the genetic factors for the risk of production of specific IgE to mite allergens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744455     DOI: 10.1007/s10038-005-0232-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

Review 1.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

2.  Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation.

Authors:  S S Cho; C M Bacon; C Sudarshan; R C Rees; D Finbloom; R Pine; J J O'Shea
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

3.  Gametic disequilibrium measures: proceed with caution.

Authors:  P W Hedrick
Journal:  Genetics       Date:  1987-10       Impact factor: 4.562

4.  Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation.

Authors:  Y L Lee; C L Fu; Y L Ye; B L Chiang
Journal:  Scand J Immunol       Date:  1999-03       Impact factor: 3.487

5.  STAT4 signal pathways regulate inflammation and airway physiology changes in allergic airway inflammation locally via alteration of chemokines.

Authors:  Kavita Raman; Mark H Kaplan; Cory M Hogaboam; Aaron Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene.

Authors:  Rebecca C J Twells; Charles A Mein; Michael S Phillips; J Fred Hess; Riitta Veijola; Matthew Gilbey; Matthew Bright; Michael Metzker; Benedicte A Lie; Amanda Kingsnorth; Edward Gregory; Yusuke Nakagawa; Hywel Snook; William Y S Wang; Jennifer Masters; Gillian Johnson; Iain Eaves; Joanna M M Howson; David Clayton; Heather J Cordell; Sarah Nutland; Helen Rance; Philippa Carr; John A Todd
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

7.  Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.

Authors:  James L Lordan; Fabio Bucchieri; Audrey Richter; Athanassias Konstantinidis; John W Holloway; Matthew Thornber; Sarah M Puddicombe; Diana Buchanan; Susan J Wilson; Ratko Djukanović; Stephen T Holgate; Donna E Davies
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Cytokine production by mite-specific T cells from donors with mild atopic disease.

Authors:  R J Looney; D Pudiak; S I Rosenfeld
Journal:  J Allergy Clin Immunol       Date:  1994-02       Impact factor: 10.793

9.  Genetic approaches to assessing evidence for a T helper type 1 cytokine defect in adult asthma.

Authors:  Illugi F Birkisson; Eva Halapi; Unnur S Bjornsdottir; Dana L Shkolny; Elva Adalsteinsdottir; Thor Arnason; David Gislason; Thorarinn Gislason; Jeffrey Gulcher; Kari Stefansson; Hakon Hakonarson
Journal:  Am J Respir Crit Care Med       Date:  2004-02-12       Impact factor: 21.405

Review 10.  Interactions between genes and environmental factors in asthma and atopy: new developments.

Authors:  Claudia Sengler; Susanne Lau; Ulrich Wahn; Renate Nickel
Journal:  Respir Res       Date:  2001-10-31
View more
  10 in total

1.  STAT4 is required for IL-23 responsiveness in Th17 memory cells and NKT cells.

Authors:  Nicole L Glosson-Byers; Sarita Sehra; Mark H Kaplan
Journal:  JAKSTAT       Date:  2014-10-30

2.  Genetic associations with viral respiratory illnesses and asthma control in children.

Authors:  D A Loisel; G Du; T S Ahluwalia; C J Tisler; M D Evans; R A Myers; R E Gangnon; E Kreiner-Møller; K Bønnelykke; H Bisgaard; D J Jackson; R F Lemanske; D L Nicolae; J E Gern; C Ober
Journal:  Clin Exp Allergy       Date:  2016-01       Impact factor: 5.018

Review 3.  Immune-related gene polymorphisms in pulmonary diseases.

Authors:  Dhirendra P Singh; Prathyusha Bagam; Malaya K Sahoo; Sanjay Batra
Journal:  Toxicology       Date:  2017-03-30       Impact factor: 4.221

Review 4.  The current status of asthma in Korea.

Authors:  Sang Heon Cho; Heung Woo Park; Daniel M Rosenberg
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

5.  STAT4-mediated transcriptional repression of the IL5 gene in human memory Th2 cells.

Authors:  Sarah R Gonzales-van Horn; Leonardo D Estrada; Nicolai S C van Oers; J David Farrar
Journal:  Eur J Immunol       Date:  2016-04-08       Impact factor: 5.532

Review 6.  STAT4: genetics, mechanisms, and implications for autoimmunity.

Authors:  Benjamin D Korman; Daniel L Kastner; Peter K Gregersen; Elaine F Remmers
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

7.  A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.

Authors:  Ulrich Steidl; Christian Steidl; Alexander Ebralidze; Björn Chapuy; Hye-Jung Han; Britta Will; Frank Rosenbauer; Annegret Becker; Katharina Wagner; Steffen Koschmieder; Susumu Kobayashi; Daniel B Costa; Thomas Schulz; Karen B O'Brien; Roel G W Verhaak; Ruud Delwel; Detlef Haase; Lorenz Trümper; Jürgen Krauter; Terumi Kohwi-Shigematsu; Frank Griesinger; Daniel G Tenen
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 8.  Wheezing and itching: The requirement for STAT proteins in allergic inflammation.

Authors:  Nicole L Glosson; Heather A Bruns; Mark H Kaplan
Journal:  JAKSTAT       Date:  2012-01-01

9.  The search for genetic variants and epigenetics related to asthma.

Authors:  Shin-Hwa Lee; Jong-Sook Park; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2011-05-30       Impact factor: 5.764

10.  Altered transcriptional and chromatin responses to rhinovirus in bronchial epithelial cells from adults with asthma.

Authors:  Britney A Helling; Débora R Sobreira; Grace T Hansen; Noboru J Sakabe; Kaixuan Luo; Christine Billstrand; Bharathi Laxman; Raluca I Nicolae; Dan L Nicolae; Yury A Bochkov; James E Gern; Marcelo A Nobrega; Steven R White; Carole Ober
Journal:  Commun Biol       Date:  2020-11-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.